How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

02/11/2015 - 5 minutes

As usual at BIO-Europe, the fair starts with an opening keynote, this time with speakers from Merck Healthcare, MedImmune/AstraZeneca and Baxalta.

The keynote is basically a discussion between high-level speakers, akin to the talk which took place in Paris during  March, when Antoine Papiernik (the prominent European VC from Sofinnova) led a panel discussion with a few other CEOs.

This year, the panel had a pretty high level of Biotech clout again, even if the selection of speakers was more oriented towards Big Pharmas than Biotech. I’ll let you judge:


Edwards introduced the discussion :

This will not be a panel discussion like the Republican ones, where none of the questions were answered

That got me excited. I thought: Great! We will have a real discussion without formal or politically correct declarations. Unfortunately, it didn’t hold true to its promise, but the discussion was still interesting…

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

Support Us

Become a Member